首页> 美国卫生研究院文献>Advanced Science >Photo‐Disassembly of Membrane Microdomains Revives Conventional Antibiotics against MRSA
【2h】

Photo‐Disassembly of Membrane Microdomains Revives Conventional Antibiotics against MRSA

机译:膜微区的光分解可恢复针对MRSA的常规抗生素

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Confronted with the rapid evolution and dissemination of antibiotic resistance, there is an urgent need to develop alternative treatment strategies for drug‐resistant pathogens. Here, an unconventional approach is presented to restore the susceptibility of methicillin‐resistant (MRSA) to a broad spectrum of conventional antibiotics via photo‐disassembly of functional membrane microdomains. The photo‐disassembly of microdomains is based on effective photolysis of staphyloxanthin, the golden carotenoid pigment that gives its name. Upon pulsed laser treatment, cell membranes are found severely disorganized and malfunctioned to defense antibiotics, as unveiled by membrane permeabilization, membrane fluidification, and detachment of membrane protein, PBP2a. Consequently, the photolysis approach increases susceptibility and inhibits development of resistance to a broad spectrum of antibiotics including penicillins, quinolones, tetracyclines, aminoglycosides, lipopeptides, and oxazolidinones. The synergistic therapy, without phototoxicity to the host, is effective in combating MRSA both in vitro and in vivo in a mice skin infection model. Collectively, this endogenous chromophore‐targeted phototherapy concept paves a novel platform to revive conventional antibiotics to combat drug‐resistant infections as well as to screen new lead compounds.
机译:面对抗生素耐药性的快速发展和传播,迫切需要为耐药病原体开发替代治疗策略。在这里,提出了一种非常规方法,可以通过光分解功能性膜微区来恢复耐甲氧西林(MRSA)对多种常规抗生素的敏感性。微区的光分解是基于金黄色黄素的有效光解,金黄色素是一种金黄色的类胡萝卜素颜料。脉冲激光处理后,发现细胞膜严重紊乱且无法防御抗生素,如膜透化,膜流化和膜蛋白PBP2a分离所揭示。因此,光解方法增加了敏感性,并抑制了对包括青霉素,喹诺酮,四环素,氨基糖苷,脂肽和恶唑烷酮在内的多种抗生素的耐药性。在小鼠皮肤感染模型中,该协同疗法对宿主无光毒性,可有效地对抗体内和体外的MRSA。总而言之,这种内生的以发色团为目标的光疗概念为复兴常规抗生素以对抗耐药性感染以及筛选新的先导化合物铺平了新的平台。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号